Efficacy and Tolerability of Lanreotide (Autogel 120 mg) in Patients With Acromegaly
Clinical trial NCT00499993 · COMPLETED
Trial details
- NCT number
- NCT00499993
- Sponsor
- Ipsen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-01-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.